TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling

Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy

(2010) C A Sparks et al.   ONCOGENE

Transient Receptor Potential Type Vanilloid 1 Suppresses Skin Carcinogenesis

(2009) A. M. Bode et al.   CANCER RESEARCH

Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner

(2009) C. Amantini et al.   CARCINOGENESIS

Akt-dependent and -independent mechanisms of mTOR regulation in cancer

(2009) Regan M. Memmott et al.   CELLULAR SIGNALLING

Capsaicin (TRPV1 Agonist) Therapy for Pain Relief

(2009) Helena Knotkova et al.   CLINICAL JOURNAL OF PAIN

TRP Channels and Pain

(2009) Daniel Cortright et al.   CURRENT PHARMACEUTICAL DESIGN

EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors

(2009) Kenji Takeuchi et al.   FEBS Journal

New Insights into mTOR Signaling: mTORC2 and Beyond

(2009) D. R. Alessi et al.   Science Signaling

The role of TRPV1 receptors in pain evoked by noxious thermal and chemical stimuli

(2009) William D. Willis   EXPERIMENTAL BRAIN RESEARCH

High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma

(2008) Xiongying Miao et al.   CANCER GENETICS AND CYTOGENETICS

The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications

(2008) Amancio Carnero et al.   CURRENT CANCER DRUG TARGETS

Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises

(2008) Timothy A Yap et al.   CURRENT OPINION IN PHARMACOLOGY

Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway

(2008) Martin J. Gunthorpe et al.   DRUG DISCOVERY TODAY

Increased expression of TRPV1 channel in intrinsically aged and photoaged human skinin vivo

(2008) Young Mee Lee et al.   EXPERIMENTAL DERMATOLOGY

Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma

(2008) Gabriella Czifra et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY